✦ LIBER ✦

Improvement in Gastrointestinal and Health-related Quality of Life Outcomes After Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Liver Transplant Recipients

✍ Scribed by Sterneck, M.; Settmacher, U.; Ganten, T.; Sarrazin, C.; Speidel, N.; Broering, D.; Heyne, N.; Paulus, E.; Mertens, M.; Fischer, L.

Book ID: 122185441
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 470 KB
Volume: 46
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2013.09.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement of gastrointestinal symptoms

Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients

✍ Alexander H. Toledo; Laura Hendrix; Valorie Buchholz; Erin Fisher; Kimberly Newt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Quality of Life in Renal Transplant Reci

Quality of Life in Renal Transplant Recipients Following Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium

✍ F. Cofan; E. Rosich; M. Arias; V. Torregrosa; F. Oppenheimer; J.M. Campistol 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Conversion From Mycophenolate Mofetil to

Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients With Gastrointestinal Tract Disorders

✍ P. Darji; R. Vijayaraghavan; C.M. Thiagarajan; R.K. Sharma; B. Subbarao; R. Pish 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Improved gastrointestinal symptom burden

Improved gastrointestinal symptom burden after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in kidney transplanted children

✍ Lars Pape; Thurid Ahlenstiel; Martin Kreuzer; Jochen H. H. Ehrich 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Reduction of Gastrointestinal Complicati

Reduction of Gastrointestinal Complications in Renal Graft Recipients after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium

✍ P. Reinke; K. Budde; C. Hugo; P. Petersen; P. Schnuelle; L. Fricke; D. Scholz; H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 513 KB

Conversion from mycophenolate mofetil to

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study

✍ Jérôme Dumortier; Marie-Claude Gagnieu; Janine Salandre; Olivier Guillaud; Phili 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of this prospective study was to evaluate the effect of conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in liver transplant patients